Will Microsoft Be a $5 Trillion Stock?
Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…
Sell
50
OMCL Quote, Financials, Valuation and Earnings
Last price:
$28.71
Seasonality move
:
6.91%
Day range:
$28.68 - $29.49
52-week range:
$22.66 - $55.75
Dividend yield:
0%
P/E ratio:
62.37x
P/S ratio:
1.18x
P/B ratio:
1.07x
Volume:
255.2K
Avg. volume:
472.1K
1-year change:
7.17%
Market cap:
$1.3B
Revenue:
$1.1B
EPS (TTM):
$0.46
Analysts' Opinion
-
Consensus RatingOmnicell has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $43.67, Omnicell has an estimated upside of 52.2% from its current price of $28.69.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $34.00 representing -18.51% downside risk from its current price of $28.69.
Fair Value
-
According to the consensus of 7 analysts, Omnicell has 52.2% upside to fair value with a price target of $43.67 per share.
OMCL vs. S&P 500
-
Over the past 5 trading days, Omnicell has underperformed the S&P 500 by -3.87% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Omnicell does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Omnicell has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Omnicell reported revenues of $269.7M.
Earnings Growth
-
Omnicell has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Omnicell reported earnings per share of -$0.15.
Enterprise value:
1.3B
EV / Invested capital:
--
Price / LTM sales:
1.18x
EV / EBIT:
121.70x
EV / Revenue:
1.13x
PEG ratio (5yr expected):
-3.94x
EV / Free cash flow:
11.96x
Price / Operating cash flow:
12.43x
Enterprise value / EBITDA:
12.99x
Gross Profit (TTM):
$489.3M
Return On Assets:
0.95%
Net Income Margin (TTM):
1.87%
Return On Equity:
1.73%
Return On Invested Capital:
1.24%
Operating Margin:
-4.31%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.3B | $1.1B | $1.1B | $246.2M | $269.7M | |
| Gross Profit | $564M | $464.4M | $489.3M | $92.6M | $110.9M | |
| Operating Income | -$30.4M | -$33.8M | $10.6M | -$21.8M | -$11.6M | |
| EBITDA | $68.6M | $60.8M | $99M | $1.3M | $10.2M | |
| Diluted EPS | -$0.40 | -$0.46 | $0.46 | -$0.34 | -$0.15 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $904M | $775.6M | $935M | $989.9M | $839.7M | |
| Total Assets | $1.9B | $2.1B | $2.3B | $2.3B | $2.2B | |
| Current Liabilities | $292.3M | $951M | $454M | $416.4M | $607.5M | |
| Total Liabilities | $875.6M | $1B | $1.1B | $1.1B | $894.4M | |
| Total Equity | $1B | $1.1B | $1.1B | $1.2B | $1.3B | |
| Total Debt | $472.3M | $564.3M | $567.3M | $570.4M | $341.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $106.5M | $218.3M | $163.7M | $50M | $25.9M | |
| Cash From Investing | -$53.6M | -$53.7M | -$56.2M | -$12.3M | -$15.7M | |
| Cash From Financing | $15M | $31.5M | -$243.5M | $11.9M | $4M | |
| Free Cash Flow | $47.5M | $164.6M | $107.5M | $37.6M | $10.2M | |
OMCL
Sector
Market Cap
$1.3B
$33.5M
Price % of 52-Week High
51.47%
48.01%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.97%
1-Year Price Total Return
7.17%
-33.61%
Beta (5-Year)
0.761
0.621
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$29.57
200-day SMA
Sell
Level
$38.08
Bollinger Bands (100)
Sell
Level
28.14 - 35.58
Chaikin Money Flow
Sell
Level
-59.1K
20-day SMA
Sell
Level
$29.18
Relative Strength Index (RSI14)
Sell
Level
43.98
ADX Line
Sell
Level
17.75
Williams %R
Neutral
Level
-65.5052
50-day SMA
Sell
Level
$29.15
MACD (12, 26)
Buy
Level
6.54
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
234.8K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3137)
Buy
CA Score
(Annual)
Level (0.0089)
Buy
Beneish M-Score
(Annual)
Level (-2.7477)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.8776)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
Stock Forecast FAQ
In the current month, OMCL has received 4 Buy ratings 3 Hold ratings, and 0 Sell ratings. The OMCL average analyst price target in the past 3 months is $43.67.
-
Where Will Omnicell Stock Be In 1 Year?
According to analysts, the consensus estimate is that Omnicell share price will rise to $43.67 per share over the next 12 months.
-
What Do Analysts Say About Omnicell?
Analysts are divided on their view about Omnicell share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Omnicell is a Sell and believe this share price will drop from its current level to $34.00.
-
What Is Omnicell's Price Target?
The price target for Omnicell over the next 1-year time period is forecast to be $43.67 according to 7 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is OMCL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Omnicell is a Buy. 4 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of OMCL?
You can purchase shares of Omnicell via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Omnicell shares.
-
What Is The Omnicell Share Price Today?
Omnicell was last trading at $28.71 per share. This represents the most recent stock quote for Omnicell. Yesterday, Omnicell closed at $28.69 per share.
-
How To Buy Omnicell Stock Online?
In order to purchase Omnicell stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will C3.ai Stock Be in 1 Year?
C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…
What Is the Ceiling for IONQ Stock?
IonQ (NYSE:IONQ) is a quantum computing startup that, like many…
Stock Ideas
Buy
69
Is NVDA Stock a Buy?
Market Cap: $4T
P/E Ratio: 56x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 43x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
58
INKT alert for Jul 12
MiNK Therapeutics [INKT] is up 727.94% over the past day.
Buy
51
NEGG alert for Jul 12
Newegg Commerce [NEGG] is up 74.03% over the past day.
Buy
68
ATRO alert for Jul 12
Astronics [ATRO] is up 16.28% over the past day.
